Gregg H. Alton
Equibles does not estimate personal net worth.
Get an email with a short summary when Gilead Sciences, Inc. publishes a filing, an earnings call transcript or a press release.
Get GILD alertsAbout Gregg H. Alton
The proxy statement of Gilead Sciences, Inc. reports total compensation of $7,843,788 for Gregg H. Alton in fiscal 2019, including a base salary of $952,627. Disclosed compensation is on record for 3 fiscal years. Gilead Sciences, Inc. is classified in the Drug Manufacturers - General industry within the Healthcare sector. Other leadership on record at Gilead Sciences, Inc. includes Daniel P. O’Day (CEO), Robin L. Washington (CFO), Diane E. Wilfong (Chief Accounting Officer) and 7 others.
Affiliation history
-
Gilead Sciences, Inc. (GILD)
Proxy statement
Current
Company network
Leadership on record at Gilead Sciences, Inc.
- Daniel P. O’Day CEO
- Robin L. Washington CFO
- Diane E. Wilfong Chief Accounting Officer
- Erin Burkhart Chief Accounting Officer
- Sandra Patterson Chief Accounting Officer
- Anthony Welters Board Member
- JEFFREY A. BLUESTONE Board Member
- Jacqueline K. Barton Board Member
- Javier J. Rodriguez Board Member
- SANDRA J. HORNING Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2019 | Gilead Sciences, Inc. (GILD) | Former Interim Chief Executive Officer and Chief Patient Officer | $952,627 | $7,843,788 |
| 2018 | Gilead Sciences, Inc. (GILD) | Former Interim Chief Executive Officer and Chief Patient Officer | $1,005,381 | $4,906,863 |
| 2017 | Gilead Sciences, Inc. (GILD) | Former Interim Chief Executive Officer and Chief Patient Officer | $956,308 | $5,216,426 |
Recent activity
No call appearances or filed executive changes recorded yet.